301126 Stock Overview
Engages in the wholesale and retail of pharmaceuticals products in China.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 2/6 |
| Dividends | 1/6 |
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.96 |
| 52 Week High | CN¥14.58 |
| 52 Week Low | CN¥6.61 |
| Beta | 0.90 |
| 11 Month Change | 24.83% |
| 3 Month Change | 19.52% |
| 1 Year Change | -9.35% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -53.76% |
Recent News & Updates
Recent updates
There's Reason For Concern Over Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Massive 41% Price Jump
Oct 08
Optimistic Investors Push Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Shares Up 30% But Growth Is Lacking
May 09Market Might Still Lack Some Conviction On Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd (SZSE:301126) Even After 31% Share Price Boost
Mar 08Shareholder Returns
| 301126 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 0.6% | 2.3% | 2.7% |
| 1Y | -9.3% | -13.7% | 4.6% |
Return vs Industry: 301126 exceeded the CN Healthcare industry which returned -13.7% over the past year.
Return vs Market: 301126 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 301126 volatility | |
|---|---|
| 301126 Average Weekly Movement | 9.2% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 7.6% |
| 10% most volatile stocks in CN Market | 11.5% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 301126 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 301126's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 3,461 | Shengli Hu | www.djwk.com.cn |
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. The company offers anabolic preparations and peptide hormones, second-class psychotropic drugs, vaccines, antibiotic raw materials, biological products, biochemical drugs, antibiotic preparations, Chinese medicine decoction pieces, chemical drug preparations, chemical raw materials, Chinese herbal medicines, Chinese patent medicines, and medical toxic drugs; medical devices; and health food products. It also provides pharmaceutical logistics services; and operates reproductive hospitals.
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd Fundamentals Summary
| 301126 fundamental statistics | |
|---|---|
| Market cap | CN¥2.25b |
| Earnings (TTM) | CN¥47.95m |
| Revenue (TTM) | CN¥4.73b |
47.0x
P/E Ratio0.5x
P/S RatioIs 301126 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301126 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.73b |
| Cost of Revenue | CN¥3.92b |
| Gross Profit | CN¥816.55m |
| Other Expenses | CN¥768.60m |
| Earnings | CN¥47.95m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Oct 30, 2024
| Earnings per share (EPS) | 0.23 |
| Gross Margin | 17.25% |
| Net Profit Margin | 1.01% |
| Debt/Equity Ratio | 164.7% |
How did 301126 perform over the long term?
See historical performance and comparison